JP2013500997A5 - - Google Patents

Download PDF

Info

Publication number
JP2013500997A5
JP2013500997A5 JP2012523088A JP2012523088A JP2013500997A5 JP 2013500997 A5 JP2013500997 A5 JP 2013500997A5 JP 2012523088 A JP2012523088 A JP 2012523088A JP 2012523088 A JP2012523088 A JP 2012523088A JP 2013500997 A5 JP2013500997 A5 JP 2013500997A5
Authority
JP
Japan
Prior art keywords
methyl
nitro
oxy
oxazine
imidazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012523088A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013500997A (ja
JP5685254B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/043908 external-priority patent/WO2011014776A1/en
Publication of JP2013500997A publication Critical patent/JP2013500997A/ja
Publication of JP2013500997A5 publication Critical patent/JP2013500997A5/ja
Application granted granted Critical
Publication of JP5685254B2 publication Critical patent/JP5685254B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012523088A 2009-07-31 2010-07-30 ニトロイミダゾオキサジンおよびニトロイミダゾオキサゾール・アナログならびにそれらの使用 Expired - Fee Related JP5685254B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23042209P 2009-07-31 2009-07-31
US61/230,422 2009-07-31
PCT/US2010/043908 WO2011014776A1 (en) 2009-07-31 2010-07-30 Nitroimidazooxazine and nitroimidazooxazole analogues and their uses

Publications (3)

Publication Number Publication Date
JP2013500997A JP2013500997A (ja) 2013-01-10
JP2013500997A5 true JP2013500997A5 (enExample) 2013-09-12
JP5685254B2 JP5685254B2 (ja) 2015-03-18

Family

ID=42829983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012523088A Expired - Fee Related JP5685254B2 (ja) 2009-07-31 2010-07-30 ニトロイミダゾオキサジンおよびニトロイミダゾオキサゾール・アナログならびにそれらの使用

Country Status (13)

Country Link
US (1) US8293734B2 (enExample)
EP (1) EP2459570B1 (enExample)
JP (1) JP5685254B2 (enExample)
KR (1) KR101738868B1 (enExample)
CN (1) CN102741259B (enExample)
AU (1) AU2010278779B2 (enExample)
BR (1) BR112012002214B1 (enExample)
CA (1) CA2769263C (enExample)
ES (1) ES2530266T3 (enExample)
NZ (1) NZ598165A (enExample)
RU (1) RU2540860C2 (enExample)
WO (1) WO2011014776A1 (enExample)
ZA (1) ZA201201259B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201012209D0 (en) * 2010-05-31 2010-09-08 Ge Healthcare Ltd In vivo imaging agent
US9051333B2 (en) 2011-04-15 2015-06-09 Otsuka Pharmaceutical Co., Ltd. 6,7-dihydroimidazo [2,1-b] [1,3]oxazine bactericides
JP2015006994A (ja) * 2011-10-28 2015-01-15 大正製薬株式会社 ジヒドロイミダゾオキサゾール誘導体
KR101918469B1 (ko) * 2012-06-04 2018-11-15 한국화학연구원 바이사이클릭 니트로이미다졸 유도체 또는 이들의 광학이성질체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약제학적 조성물
US10301294B2 (en) * 2013-03-13 2019-05-28 The Broad Institute Inc. Compounds for the treatment of tuberculosis
CN104059082B (zh) * 2013-03-21 2016-08-03 苏州迈泰生物技术有限公司 硝基咪唑杂环类化合物及其在制备治疗结核病药物中的应用
KR101564425B1 (ko) 2013-11-26 2015-10-30 한국화학연구원 신규한 바이사이클릭 니트로이미다졸 카바메이트 화합물, 이를 제조하는 방법 및 이를 유효성분으로 함유하는 결핵 질환의 예방 또는 치료용 약제학적 조성물
TWI687409B (zh) 2014-08-28 2020-03-11 日商大塚製藥股份有限公司 稠合雜環化合物
KR101682356B1 (ko) 2014-11-04 2016-12-06 한국화학연구원 이미다조 옥사진 유도체, 이의 약학적으로 허용 가능한 염 또는 이의 광학이성질체 및 이를 유효성분으로 함유하는 약제학적 조성물
JP6542900B2 (ja) 2015-01-29 2019-07-10 メッドシャイン ディスカバリー インコーポレイテッド 抗肺結核症のニトロイミダゾール誘導体
GB201519054D0 (en) * 2015-10-28 2015-12-09 Univ Dundee Composition
US10851079B2 (en) 2016-02-26 2020-12-01 Otsuka Pharmaceutical Co., Ltd. Piperidine derivative
CN108727406B (zh) 2017-03-28 2021-12-07 北京协和制药二厂 含氮杂环取代的苯并噁嗪噁唑烷酮类化合物及其制备方法和用途
JP7530384B2 (ja) * 2019-05-01 2024-08-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング (r)-(2-メチルオキシラン-2-イル)メチル 4-ブロモベンゼンスルホネート
WO2023114170A1 (en) 2021-12-14 2023-06-22 Boehringer Ingelheim International Gmbh Aldosterone synthase inhibitors for treating chronic kidney disease
CN114249747A (zh) * 2021-12-27 2022-03-29 苏州虞美景盛新药开发有限公司 一种用于治疗广泛耐药性结核病的硝基咪唑吡喃类药物的新合成工艺

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH568715A5 (enExample) 1972-03-16 1975-11-14 Ciba Geigy Ag
IL41744A0 (en) 1972-03-16 1973-05-31 Ciba Geigy Ag New aryl ether derivatives,their production and their use as pesticides
FR2575158B1 (fr) 1984-12-20 1987-10-02 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
SU1271861A1 (ru) * 1985-05-07 1986-11-23 Иркутский институт органической химии СО АН СССР Способ получени 2,2-диметил-3-цианометилиденбензимидазо @ 2,1- @ -1,3-оксазолидина
US6087358A (en) 1995-06-26 2000-07-11 Pathogenesis Corporation Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof
US5668127A (en) 1995-06-26 1997-09-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof
TWI347946B (en) * 2002-10-11 2011-09-01 Otsuka Pharma Co Ltd 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
RU2365593C2 (ru) 2003-10-31 2009-08-27 Оцука Фармасьютикал Ко., Лтд. ПРОИЗВОДНЫЕ 2,3-ДИГИДРО-6-НИТРОИМИДАЗО [2,1-b] ОКСАЗОЛА ДЛЯ ЛЕЧЕНИЯ ТУБЕРКУЛЕЗА
JP4787529B2 (ja) 2004-04-09 2011-10-05 大塚製薬株式会社 医薬組成物
JP4789966B2 (ja) 2004-04-09 2011-10-12 大塚製薬株式会社 医薬組成物
US7115736B2 (en) 2004-09-17 2006-10-03 Daiso Co., Ltd. Process for preparing imidazopyran derivatives
CN101268084A (zh) * 2005-07-28 2008-09-17 沃泰克斯药物股份有限公司 天冬氨酸特异性半胱氨酸蛋白酶抑制剂前体药物
JP2009521464A (ja) 2005-12-23 2009-06-04 ノバルティス アクチエンゲゼルシャフト ニトロイミダゾール化合物
US20070213341A1 (en) 2006-03-13 2007-09-13 Li Chen Spiroindolinone derivatives
US7678791B2 (en) 2006-07-12 2010-03-16 Cumbre Ip Ventures, L.P. Nitroheteroaryl-containing rifamycin derivatives
SG179453A1 (en) 2007-03-09 2012-04-27 Sanofi Aventis Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
CA2712613C (en) 2008-03-26 2017-02-28 Global Alliance For Tb Drug Development Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones

Similar Documents

Publication Publication Date Title
JP2013500997A5 (enExample)
RU2012107180A (ru) Нитроимидазооксазиновые и нитроимидазооксазольные аналоги и их применение
US20230348418A1 (en) Isoindolinone compounds
US9844553B2 (en) Pyrazolopyridyl compounds as aldosterone synthase inhibitors
US9382226B2 (en) Aldosterone synthase inhibitors
ES2640482T3 (es) Derivados biaromáticos antibacterianos
US9518055B2 (en) Imidazopyridyl compounds as aldosterone synthase inhibitors
TWI749042B (zh) 作為飢餓素o-醯基轉移酶(goat)抑制劑的㗁二唑吡啶衍生物
JP2014513110A5 (enExample)
RU2011121567A (ru) Изоиндолиновые соединения для применения при лечении рака
JP2009538897A5 (enExample)
JP2008513516A5 (enExample)
RU2011108281A (ru) Трипиридилкарбоксамидные антагонисты орексиновых рецепторов
EP2909193A1 (en) Phenyl linked quinolinyl modulators of ror-gamma-t
JP2013500996A5 (enExample)
US9567333B2 (en) Triazolopyridyl compounds as aldosterone synthase inhibitors
CA2798375A1 (en) Substituted heterocyclyl benzyl pyrazoles, and use thereof
RU2012107176A (ru) Нитроимидазооксазины и их применения при противотуберкулезной терапии
EP2699557A1 (en) Aromatic amides and uses thereof
US20160304486A1 (en) Indoline compounds as aldosterone synthase inhibitors
RU2016129189A (ru) Производные 3-(5-хлор-2-оксобензо[d]оксазол-3(2н)-ил)пропановой кислоты в качестве кмо ингибиторов
JP2017501174A5 (enExample)
RU2013142888A (ru) Новые азаспиродеканоны
EP4511366A1 (en) Kit inhibitors
JP2014525929A5 (enExample)